Tag: 30-month stay
30-Month Stay: How Litigation Delays Generic Drug Approval
Dec, 11 2025
The 30-month stay under the Hatch-Waxman Act lets brand drug companies delay generic approval by filing patent lawsuits. This legal tool, meant to protect innovation, often extends drug monopolies by years-costing patients billions.
Read Article→Categories
online pharmacy
generic drugs
medication safety
side effects
Hatch-Waxman Act
dosage
counterfeit drugs
patent litigation
medication side effects
generic substitution
medication adherence
benefits
pharmacy alternatives
pain relief
alternatives
family support
Parkinson's disease
motor symptoms
blood sugar control
warfarin